Nitarsone
 | |
| Names | |
|---|---|
| IUPAC name
(4-Nitrophenyl)arsonic acid | |
| Other names
(p-Nitrophenyl)arsonic acid; 4-Nitrobenzenearsonic acid | |
| Identifiers | |
| ChemSpider | 60190 |
| |
| Jmol-3D images | Image |
| PubChem | 66826 |
| |
| Properties | |
| Molecular formula |
C6H6AsNO5 |
| Molar mass | 247.04 g·mol−1 |
| Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
| Infobox references | |
Nitarsone is an organoarsenic compound that is used in poultry production as a feed additive to increase weight gain, improve feed efficiency, and prevent blackhead disease.[1] It is marketed as Histostat by Zoetis, a publicly traded subsidiary of Pfizer.[2]
Nitarsone is one of four arsenical animal drugs approved by the U.S. Food and Drug Administration for use in poultry, along with roxarsone, arsanilic acid, and carbarsone.[3] Following the 2011 suspension of roxarsone sales in the United States, however, it is believed to be the only arsenical animal drug currently marketed in the U.S.[3][4] In September 2013, the FDA announced that Zoetis and Fleming Laboratories would voluntarily withdraw current roxarsone, arsanilic acid, and carbarsone approvals, leaving only nitarsone approvals in place.[5] When the withdrawals occur, nitarsone will be the only arsenical approved for use in food animals in the U.S.
References
- ↑ U.S. Food and Drug Administration. "Animal Drugs @ FDA".
- ↑ Zoetis. "Histostat: Type A Medicated Feed Article".
- ↑ 3.0 3.1 U.S. Food and Drug Administration (June 8, 2011). "Questions and Answers Regarding 3-Nitro (Roxarsone)".
- ↑ Sabrina Tavernise (May 11, 2013). "Study Finds an Increase in Arsenic Levels in Chicken". New York Times.
- ↑ U.S. Food and Drug Administration (September 20, 2011). "FDA Response to Citizen Petition on Arsenic-based Animal Drugs".